Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2023.7696
Abstract: Importance Despite a lack of effectiveness data in humans, tecovirimat was widely prescribed to people with HIV (PWH) with mpox during the 2022 mpox epidemic, particularly PWH with low CD4+ T-cell counts or severe mpox… read more here.
Keywords: tecovirimat group; tecovirimat; early tecovirimat; mpox disease ... See more keywords